Recent developments with Mainz Biomed N.V (MYNZ) have led to the company’s beta value being reach 0.31 cents.
On Tuesday, Mainz Biomed N.V (NASDAQ: MYNZ) was 11.28% up from the session before settling in for the closing price of $7.09. A 52-week range